The efficacy of inhibiting tumour necrosis factor and interleukin 1 in patients with rheumatoid arthritis: a meta-analysis and adjusted indirect comparisons
New treatments that inhibit the cytokines tumour necrosis factor alpha (TNFalpha) and interleukin 1 (IL-1) in the treatment of rheumatoid arthritis have proven clinical effect against placebo and methotrexate (MTX) in several clinical trials in early and late-stage disease and different severity gro...
Uloženo v:
| Hlavní autoři: | , , |
|---|---|
| Médium: | Revisão |
| Jazyk: | angličtina |
| Vydáno: |
2007
|
| On-line přístup: | https://doi.org/10.1093/rheumatology/kem072 https://academic.oup.com/rheumatology/article-pdf/46/7/1140/9449311/kem072.pdf |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|